136 related articles for article (PubMed ID: 37110589)
1. Synthesis and Evaluation of Novel Nitric Oxide-Donating Ligustrazine Derivatives as Potent Antiplatelet Aggregation Agents.
Li HX; Tian JH; Li HY; Wan X; Zou Y
Molecules; 2023 Apr; 28(8):. PubMed ID: 37110589
[TBL] [Abstract][Full Text] [Related]
2. Ligustrazine derivatives. Part 3: Design, synthesis and evaluation of novel acylpiperazinyl derivatives as potential cerebrocardiac vascular agents.
Cheng XC; Liu XY; Xu WF; Guo XL; Zhang N; Song YN
Bioorg Med Chem; 2009 Apr; 17(8):3018-24. PubMed ID: 19329327
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, and biological activities of novel Ligustrazine derivatives.
Cheng XC; Liu XY; Xu WF; Guo XL; Ou Y
Bioorg Med Chem; 2007 May; 15(10):3315-20. PubMed ID: 17383884
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of novel indole hydrazone derivatives and evaluation of their antiplatelet aggregation activity.
Mashayekhi V; Haj Mohammad Ebrahim Tehrani K; Amidi S; Kobarfard F
Chem Pharm Bull (Tokyo); 2013; 61(2):144-50. PubMed ID: 23154304
[TBL] [Abstract][Full Text] [Related]
5. N-substituted indole carbohydrazide derivatives: synthesis and evaluation of their antiplatelet aggregation activity.
Mirfazli SS; Kobarfard F; Firoozpour L; Asadipour A; Esfahanizadeh M; Tabib K; Shafiee A; Foroumadi A
Daru; 2014 Sep; 22(1):65. PubMed ID: 25238875
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of nitric oxide (NO)-hydrogen sulfide (H
Wang XL; Wang ZY; Ling JJ; Zhang YH; Yin J
Chin J Nat Med; 2016 Dec; 14(12):946-953. PubMed ID: 28262123
[TBL] [Abstract][Full Text] [Related]
7. Novel thienylacylhydrazone derivatives inhibit platelet aggregation through cyclic nucleotides modulation and thromboxane A2 synthesis inhibition.
Brito FC; Kummerle AE; Lugnier C; Fraga CA; Barreiro EJ; Miranda AL
Eur J Pharmacol; 2010 Jul; 638(1-3):5-12. PubMed ID: 20412790
[TBL] [Abstract][Full Text] [Related]
8. [Design, synthesis and anti-platelet aggregation activities of ligustrazine-tetrahydroisoquinoline derivatives].
Xie D; Zhang EL; Li JM; Wang J; He GW
Yao Xue Xue Bao; 2015 Mar; 50(3):326-31. PubMed ID: 26118112
[TBL] [Abstract][Full Text] [Related]
9. [Synthesis and biological evaluation of novel chalcone aromatic oxygen alkyl acids compounds].
Huang WJ; Xie D; Li JM; Zhang YC; Zuo J; Liu HC
Yao Xue Xue Bao; 2016 Apr; 51(4):600-5. PubMed ID: 29859530
[TBL] [Abstract][Full Text] [Related]
10. Ligustrazine derivatives. Part 5: design, synthesis and biological evaluation of novel ligustrazinyloxy-cinnamic acid derivatives as potent cardiovascular agents.
Chen H; Li G; Zhan P; Liu X
Eur J Med Chem; 2011 Nov; 46(11):5609-15. PubMed ID: 21993151
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and evaluation of nitric oxide releasing derivatives of 3-n-butylphthalide as antiplatelet and antithrombotic agents.
Wang X; Li Y; Zhao Q; Min Z; Zhang C; Lai Y; Ji H; Peng S; Zhang Y
Org Biomol Chem; 2011 Aug; 9(16):5670-81. PubMed ID: 21706121
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of nitric oxide releasing derivatives of 6-amino-3-n-butylphthalide as potential antiplatelet agents.
Wang X; Wang L; Huang Z; Sheng X; Li T; Ji H; Xu J; Zhang Y
Bioorg Med Chem Lett; 2013 Apr; 23(7):1985-8. PubMed ID: 23481646
[TBL] [Abstract][Full Text] [Related]
13. Pyrazole derivatives as inhibitors of arachidonic acid-induced platelet aggregation.
Levent S; Çalışkan B; Çiftçi M; Özkan Y; Yenicesu I; Ünver H; Banoglu E
Eur J Med Chem; 2013 Jun; 64():42-53. PubMed ID: 23639653
[TBL] [Abstract][Full Text] [Related]
14. Ligustrazine inhibits platelet activation via suppression of the Akt pathway.
Li L; Chen H; Shen A; Li Q; Chen Y; Chu J; Liu L; Peng J; Chen K
Int J Mol Med; 2019 Jan; 43(1):575-582. PubMed ID: 30387814
[TBL] [Abstract][Full Text] [Related]
15. Structure-activity relationship studies on chalcone derivatives: potent inhibition of platelet aggregation.
Ko HH; Hsieh HK; Liu CT; Lin HC; Teng CM; Lin CN
J Pharm Pharmacol; 2004 Oct; 56(10):1333-7. PubMed ID: 15482650
[TBL] [Abstract][Full Text] [Related]
16. In vitro study of the anti-aggregating activity of two nitroderivatives of acetylsalicylic acid.
Lechi C; Gaino S; Tommasoli R; Zuliani V; Bonapace S; Fontana L; Degan M; Lechi A; Minuz P
Blood Coagul Fibrinolysis; 1996 Mar; 7(2):206-9. PubMed ID: 8735820
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of 4-alkoxy-2-phenylquinoline derivatives as potent antiplatelet agents.
Ko TC; Hour MJ; Lien JC; Teng CM; Lee KH; Kuo SC; Huang LJ
Bioorg Med Chem Lett; 2001 Feb; 11(3):279-82. PubMed ID: 11212091
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of N6-alkyl(aryl)-2-alkyl(aryl)thioadenosines as antiplatelet agents.
Liu G; Xu J; Chen N; Zhang S; Ding Z; Du H
Eur J Med Chem; 2012 Jul; 53():114-23. PubMed ID: 22531380
[TBL] [Abstract][Full Text] [Related]
19. Alditols and monosaccharides from sorghum vinegar can attenuate platelet aggregation by inhibiting cyclooxygenase-1 and thromboxane-A2 synthase.
Li J; Yu G; Fan J
J Ethnopharmacol; 2014 Aug; 155(1):285-92. PubMed ID: 24877847
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, and biological evaluation of 4-methoxy-3-arylamido-N-(substitutedphenyl)benzamide derivatives as potential antiplatelet agents.
Liu X; Chen X; Qiu K; Zhang Z
Arch Pharm (Weinheim); 2020 Feb; 353(2):e1900231. PubMed ID: 31808975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
